Purpose of the Assessment
- Accurately differentiate between benign fibroids and uterine sarcoma
- Determine the most appropriate treatment strategy based on risk level
- Minimize the need for unnecessary surgical interventions
Book Uterine Sarcoma Risk Assessment | Lahalak Medical Platform
Protect your health with our comprehensive uterine sarcoma risk assessment. We utilize advanced laboratory and imaging techniques to ensure diagnostic accuracy and personalized care within high-risk pregnancy management.
Scientific name: Uterine Sarcoma Risk Stratification Program
A multimodal medical assessment using LDH isoenzymes, MRI features (DWI), and clinical markers to risk-stratify uterine sarcomas, ensuring early detection and effective management strategies.
Service type
Integrated Diagnostic Program
Duration
2-3 hours
Fasting
6-8 hours of fasting
Included Services
- LDH Isoenzymes Analysis
- MRI with Diffusion-Weighted Imaging
- Clinical Marker Assessment
- Specialist Consultation
Medical Service Information
Target Groups
- Women with rapidly growing uterine masses
- High-risk pregnancy cases with suspicious uterine findings
- Patients with a strong family history of uterine malignancies
Frequently Asked Questions
- Is the procedure painful? No, it involves blood work and non-invasive imaging.
- When will results be ready? Results are typically available within 3-5 working days.
Conditions & Notices
- Full medical history is required
- Prior scheduling for MRI is necessary
Medical services you might also like
